Related Experiment Videos
Opioid peptide. Structure-activity relationships in dermorphin tetrapeptide-amides. II
Il Farmaco; Edizione Scientifica
|October 1, 1982
Summary
Researchers synthesized novel dermorphin analogs. Certain C-terminal amide modifications yielded potent opioid peptides with significant central and peripheral activity, surpassing original dermorphins.
Area of Science:
- Medicinal Chemistry
- Pharmacology
- Neuroscience
Background:
- Dermorphin, an opioid heptapeptide, is known for its potent analgesic properties.
- Exploration of synthetic analogs is crucial for developing novel therapeutics with improved profiles.
- Understanding structure-activity relationships is key to optimizing peptide-based drugs.
Purpose of the Study:
- To synthesize and pharmacologically characterize novel tetrapeptide-amide analogs of dermorphin.
- To investigate the impact of C-terminal derivatization on opioid activity.
- To identify analogs with enhanced peripheral and central opioid effects.
Main Methods:
- Synthesis of sixteen tetrapeptide-amide analogs.
- Pharmacological evaluation of N,N-dialkylamides and C-terminal amide derivatives.
- Assessment of peripheral and central opioid activities.
Main Results:
- N,N-dialkylamide analogs showed reduced or no opioid activity.
- Derivatization of the C-terminus with specific amide moieties (1-adamantanamine, 1-adamantane-methylamino, D-alpha-methylbenzylamine) resulted in potent analogs.
- These potent analogs exhibited peripheral and central opioid activities comparable to or exceeding those of dermorphins.
Conclusions:
- Specific C-terminal amide modifications are critical for potent opioid activity in dermorphin analogs.
- Novel synthetic analogs demonstrate potential as effective analgesics with both central and peripheral actions.
- Further research into these analogs could lead to the development of new pain management therapies.